Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia

NCT07759895 is registered in ClinicalTrials.gov with Amit Lotan as lead sponsor.

NCT NCT07759895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07759895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia
Lead sponsor
Amit Lotan
Phase
Phase 2
Overall status
Recruiting
Start date
August 12, 2026
Completion date
December 31, 2029
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffecitve disorder, schizophrenia and predominant negative symptoms, schizophrenia and schizoaffective disorder